These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Measurement of treatment efficacy in diabetes: effect of atherosclerosis prevention and general effects]. Czech A; Szczeklik-Kumala Z Pol Merkur Lekarski; 1997 Jan; 2(7):49-51. PubMed ID: 9296902 [TBL] [Abstract][Full Text] [Related]
6. [Microangiopathic complications in type 2 diabetes]. Strojek K; Grzeszczak W Wiad Lek; 1998; 51 Suppl 2():45-51. PubMed ID: 9686533 [TBL] [Abstract][Full Text] [Related]
7. [Seminar on "problems of the diabetic patient". Theme "Vascular complications of the diabetic patient on saccharin"]. Vaissman I Hospital (Rio J); 1969 Dec; 76(6):1957-68. PubMed ID: 5309242 [No Abstract] [Full Text] [Related]
9. [Prevention of arteriosclerosis with the insulin sensitizer pioglitazone. Early intervention in diabetic patients compensates "cell ignorance"]. MMW Fortschr Med; 2002 May; 144(21):52-3. PubMed ID: 12134427 [No Abstract] [Full Text] [Related]
10. [Control of atherosclerosis in diabetes mellitus]. Quiroz Martínez A Arch Cardiol Mex; 2003; 73 Suppl 1():S125-7. PubMed ID: 12966662 [TBL] [Abstract][Full Text] [Related]
11. Diabetic complications and their prevention or reversal. Danowski TS; Ohlsen P; Fisher ER Diabetes Care; 1980; 3(1):94-9. PubMed ID: 7408616 [TBL] [Abstract][Full Text] [Related]
12. [Diabetes and arteriosclerosis]. Müller R Hippokrates; 1971 Mar; 42(1):123-4. PubMed ID: 5550578 [No Abstract] [Full Text] [Related]
13. Glucose intolerance, diabetes mellitus and atherosclerosis; prospects for prevention. Keen H Postgrad Med J; 1976 Jul; 52(609):445-51. PubMed ID: 967763 [TBL] [Abstract][Full Text] [Related]
14. Prevention of atherosclerosis in diabetes: emphasis on treatment for the abnormal lipoprotein metabolism of diabetes. Kim DK; Escalante DA; Garber AJ Clin Ther; 1993; 15(5):766-78; discussion 765. PubMed ID: 8269443 [TBL] [Abstract][Full Text] [Related]
15. The JBS-2 guidelines on prevention of cardiovascular disease in clinical practice: an opportunity missed. Jessani S; Lip GY; Barnett A; Millane T QJM; 2007 Feb; 100(2):121-4. PubMed ID: 17277318 [No Abstract] [Full Text] [Related]
16. Long-term juvenile diabetes treated with unmeasured diet. Knowles HC Trans Assoc Am Physicians; 1971; 84():95-101. PubMed ID: 5164308 [No Abstract] [Full Text] [Related]
17. Standards of medical care in diabetes. American Diabetes Association Diabetes Care; 2005 Jan; 28 Suppl 1():S4-S36. PubMed ID: 15618112 [No Abstract] [Full Text] [Related]
18. Acarbose in the prevention of cardiovascular disease in subjects with impaired glucose tolerance and type 2 diabetes mellitus. Delorme S; Chiasson JL Curr Opin Pharmacol; 2005 Apr; 5(2):184-9. PubMed ID: 15780829 [TBL] [Abstract][Full Text] [Related]
19. Current concepts and controversies in the pathogenesis, prevention, and treatment of the macrovascular complications of diabetes. Mazzone T J Lab Clin Med; 2000 Jun; 135(6):437-43. PubMed ID: 10850642 [No Abstract] [Full Text] [Related]
20. [The anti-atherosclerotic effect of metformin in the initial phases of diabetes mellitus in adults]. Baraldi B; Maestri G; Cusimano A; Valenti C; Tiraboschi L; Cocuzza E; Angeli G Clin Ter; 1980 Mar; 92(6):657-69. PubMed ID: 7006885 [No Abstract] [Full Text] [Related] [Next] [New Search]